Congenital pneumonia due to Pseudomonas
ICD-10 P23.5 is a billable code used to indicate a diagnosis of congenital pneumonia due to pseudomonas.
Congenital pneumonia due to Pseudomonas is a serious neonatal condition characterized by the presence of pneumonia in a newborn that is caused by the bacterium Pseudomonas aeruginosa. This condition typically arises when the pathogen is transmitted from the mother to the fetus during pregnancy, often due to maternal infections or colonization. The clinical presentation may include respiratory distress, tachypnea, grunting, and cyanosis shortly after birth. Diagnosis is confirmed through clinical evaluation, imaging studies such as chest X-rays, and microbiological cultures. Management often requires intensive care, including oxygen therapy, mechanical ventilation, and antibiotic treatment tailored to the specific pathogen. Early recognition and intervention are crucial to improve outcomes, as congenital pneumonia can lead to significant morbidity and mortality in neonates.
Neonatal documentation must include detailed respiratory assessments, maternal health history, and treatment plans.
Common scenarios include premature infants with respiratory distress and full-term infants presenting with signs of infection.
Neonatologists must ensure that all clinical findings are documented to support the diagnosis of congenital pneumonia.
Pediatric documentation should reflect ongoing assessments and management of respiratory conditions stemming from perinatal issues.
Pediatricians may encounter cases where congenital pneumonia leads to long-term respiratory issues requiring follow-up.
Pediatric coding must accurately reflect the history of the condition and any interventions performed.
Used for neonates with respiratory distress due to congenital pneumonia.
Document the need for CPAP based on clinical assessment and response to treatment.
Neonatologists should ensure that the rationale for CPAP use is clearly articulated in the medical record.
Key signs include respiratory distress, tachypnea, grunting, and cyanosis. Early identification and treatment are critical for improving outcomes.
